Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
about
Opening up the window into "chemobrain": a neuroimaging reviewVerbal fluency in breast cancer patients treated with chemotherapy.Altered cerebral blood flow one month after systemic chemotherapy for breast cancer: a prospective study using pulsed arterial spin labeling MRI perfusionApolipoprotein E genotype and cognitive function in postmenopausal women with early-stage breast cancer.Impact of increasing physical activity on cognitive functioning in breast cancer survivors: Rationale and study design of Memory & Motion.Associations Between Physical Fitness Indices and Working Memory in Breast Cancer Survivors and Age-Matched ControlsA feasibility study exploring the role of pre-operative assessment when examining the mechanism of 'chemo-brain' in breast cancer patientsInhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.Polymorphisms in DNA repair and oxidative stress genes associated with pre-treatment cognitive function in breast cancer survivors: an exploratory studyNeuroimaging biomarkers and cognitive function in non-CNS cancer and its treatment: current status and recommendations for future research.Cognitive impairment in gynecologic cancers: a systematic review of current approaches to diagnosis and treatment.Cognitive impairment following hormone therapy: current opinion of research in breast and prostate cancer patients.Relationship between fruit and vegetable intake and interference control in breast cancer survivors.Lack of a chemobrain effect for adjuvant FOLFOX chemotherapy in colon cancer patients. A pilot study.Persistent cognitive changes in breast cancer patients 1 year following completion of chemotherapy.
P2860
Q30596880-FE9BD6BB-8B95-4580-98D9-826F8DA6D328Q33575742-EE69E062-C32F-463B-BF51-0610EE726ABDQ33590378-3018099B-6E18-49E0-84CE-53E3BAFBA87BQ35523936-D834E108-30F8-4AC5-BB3E-C3921C9DC412Q36359668-9574B027-D98C-4E2F-A0A7-E3657023E6C9Q36543428-93F0235C-918C-43B4-8263-4C48A5533FE9Q36754399-0D88E228-EB87-4798-A5BE-6B92CF7BCEDDQ36755634-F3FF93C9-F2C1-42F9-948A-CEED7A7A2956Q36783852-DA4D9A70-765B-4D9F-99EE-5B6954211FB0Q37540122-7452BC1D-E550-4F9A-9E80-28D62756457DQ38161296-435FEA53-E2D7-4D6C-BAF9-D736E5A016E5Q38786134-AD703F27-9ABC-453D-ACC8-905F3FDB8DB6Q40783797-003FC570-D20B-48DE-B0C7-E9493FAF2D31Q43626249-80950BDE-2917-4AE6-8203-B181A6E7F15CQ45111650-AD45B6B8-DF98-4F25-BD60-FD2339ACE354
P2860
Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@en
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@nl
type
label
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@en
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@nl
prefLabel
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@en
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@nl
P2093
P2860
P1433
P1476
Neurocognitive effects of chem ...... t cancer: recent perspectives.
@en
P2093
Alan V Kalueff
Barbara A Drew
Barbara S Beckman
Caroline H Walker
James W Antoon
P2860
P304
P356
10.3109/07357907.2011.636116
P577
2012-02-01T00:00:00Z